About 30% of patients with periodic paralysis have unknown genetic mutation, making identification and treatment a challenge. Here: key points on genetics, testing, and subtypes of PPP.
Veronica Hackethal, MD
Because symptoms of periodic paralysis may overlap with other neurological or medical conditions and genetic testing is not always routinely available, exercise test methods can be key.
An emerging class of cancer drugs may help treat brain disorders such as amyotrophic lateral sclerosis frontotemporal dementia.
A large study found an association between consumption of foods high in omega-3s and severe headache.
New research might make the case for a new headache subtype called “cochlear migraine.”
If your patient is a construction worker, bus driver, gas station attendant, or mechanic, take notice: “This type of exposure deserves more attention and study as we work to develop a better understanding of what causes ALS,” notes the author of a recent study.
Perceptive neurologists have discovered a new type of vertigo. So far, the cause is unknown, though treatment seems to be effective.
Advances in technology are broadening treatment options for patients with major neurocognitive dysfunction.
What is known about chronic inflammatory demyelinating polyradiculoneuropathy, a neurological disorder marked by by progressive weakness and impaired sensory function in the extremeties?
Smoking, organic solvents, and genetic susceptibility combine to increase MS risk.